Back to Search
Start Over
Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors.
- Source :
-
The Journal of steroid biochemistry and molecular biology [J Steroid Biochem Mol Biol] 2010 Jun; Vol. 120 (4-5), pp. 164-71. Date of Electronic Publication: 2010 Apr 23. - Publication Year :
- 2010
-
Abstract
- Defects in epigenetic regulation of gene transcription play an important role in carcinogenesis of the breast and other tissues. The two most widely studied epigenetic changes are DNA methylation and acetylation of histone proteins and inhibition of these processes inhibits growth in breast cancer cell lines. These data coupled with the evidence that fetal and neonatal exposure to oestrogenic substances may lead to epigenetic changes that predispose or protect against the development of breast cancer in later life formed the basis for this study. Three histone deacetylases, valproic acid (VPA), trichostatin A (TCA) and apicidin dose-dependently inhibited basal growth in MCF-7 and MDA-MB-231 as well as the growth promoting effects of oestradiol (E(2)) and epidermal growth factor (EGF) in MCF-7 cells. The growth inhibitory responses to the DNA methyl transferase inhibitor, 5-aza-2'deoxycytidine (decitabine) were weak. HDACi's reduced the protein levels of pro-caspase 9 and cyclin D1, whereas decitabine had no effect. Long-term genistein treatment (LTGT) of MCF-7 cells markedly reduced the basal expression of acetylated histone 3 (H3) and the effects of HDACi's on increasing the levels of acetylated H3 protein. However, this was not correlated with a reduced expression of total H3 except after a high dose of VPA. LTGT inhibited growth of MCF-7 cells and the mitogenic responses to E(2) and EGF. The growth inhibitory responses to HDACI's in the presence of E(2) and EGF was significantly reduced in LTGT cells compared to control MCF-7 cells and there was evidence that LTGT maintained the protein levels of pro-caspase 9 in the presence of HDACi's. This study provides further evidence that oestrogenic substances can induce significant epigenetic changes to alter the dynamics of growth in breast cancer cell lines.<br /> (Copyright 2010 Elsevier Ltd. All rights reserved.)
- Subjects :
- Acetylation drug effects
Caspase 9 genetics
Caspase 9 metabolism
Cell Line, Tumor
Cell Proliferation drug effects
Cyclin D1 genetics
Cyclin D1 metabolism
Epigenesis, Genetic
Female
Gene Expression drug effects
Gene Expression Regulation, Neoplastic drug effects
Histones genetics
Humans
Anticarcinogenic Agents therapeutic use
Breast Neoplasms drug therapy
Genistein therapeutic use
Histone Deacetylase Inhibitors pharmacology
Histones metabolism
Mitogens pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1220
- Volume :
- 120
- Issue :
- 4-5
- Database :
- MEDLINE
- Journal :
- The Journal of steroid biochemistry and molecular biology
- Publication Type :
- Academic Journal
- Accession number :
- 20399854
- Full Text :
- https://doi.org/10.1016/j.jsbmb.2010.04.007